News

Tele2 AB (TLTZF) reports a robust 15% increase in underlying EBITDAaL, while navigating macroeconomic headwinds and strategic transformations.
Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...
Recent portfolio additions are yielding slightly below the 7.6% core yield reported for Q2 2025, as noted by Jason Estes.
Summit Therapeutics surged by 16.05 percent on Wednesday to close at $28.27 apiece, leading the rally of the overall ...
Bank OZK (OZK) stock gained 1.1% in Thursday after-hours trading after the bank posted record earnings that exceeded the Wall ...
Stocks jumped to record highs on Thursday, with investors brushing off the latest Trump-Powell drama to focus on strong ...